SB 278

  • Louisiana Senate Bill
  • 2022 Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

PHARMACEUTICALS: Provides relative to the maximum cost of prescription insulin drugs. (8/1/22)

Abstract

Bill Sponsors (1)

Votes


No votes to display

Actions


Mar 14, 2022

Senate

Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.

Mar 03, 2022

Senate

Prefiled and under the rules provisionally referred to the Committee on Insurance.

Bill Text

Bill Text Versions Format
SB278 Original PDF

Related Documents

Document Format
Digest of SB278 Original PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Louisiana Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.